Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2026-01-23 @ 3:25 PM
Study NCT ID:
NCT01479868
Status:
COMPLETED
Last Update Posted:
2014-10-29
First Post:
2011-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1
Sponsor:
Janssen R&D Ireland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-18
First Submit QC Date:
None
Study First Post Date:
2011-11-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-26
Results First Submit QC Date:
None
Results First Post Date:
2014-10-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-28
Last Update Post Date:
2014-10-29
Last Update Post Date Type:
ESTIMATED